398 related articles for article (PubMed ID: 21149769)
1. Are statins effective in high-risk primary prevention?
Dentali F; Guasti L
Arch Intern Med; 2010 Dec; 170(22):2042-3; author reply 2043-4. PubMed ID: 21149769
[No Abstract] [Full Text] [Related]
2. Statins and all-cause mortality in high-risk primary prevention: a second look at the results.
Chodick G; Shalev V
Arch Intern Med; 2010 Dec; 170(22):2041-2; author reply 2043-4. PubMed ID: 21149767
[No Abstract] [Full Text] [Related]
3. Statins and all-cause mortality in high-risk primary prevention of patients with cardiovascular risk factors.
Brugts JJ; Deckers JW
Arch Intern Med; 2010 Dec; 170(22):2041; author reply 2043-4. PubMed ID: 21149768
[No Abstract] [Full Text] [Related]
4. Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants.
Ray KK; Seshasai SR; Erqou S; Sever P; Jukema JW; Ford I; Sattar N
Arch Intern Med; 2010 Jun; 170(12):1024-31. PubMed ID: 20585067
[TBL] [Abstract][Full Text] [Related]
5. Benefit/risk ratio of statins in primary prevention.
Reidenberg MM
Clin Pharmacol Ther; 2008 Mar; 83(3):498-500. PubMed ID: 17538549
[No Abstract] [Full Text] [Related]
6. [Primary prevention of cardiovascular diseases with statins in women].
Alici G; Karpuz V; Karpuz H
Turk Kardiyol Dern Ars; 2009 Jun; 37(4):273-80. PubMed ID: 19717964
[TBL] [Abstract][Full Text] [Related]
7. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.
Mills EJ; Rachlis B; Wu P; Devereaux PJ; Arora P; Perri D
J Am Coll Cardiol; 2008 Nov; 52(22):1769-81. PubMed ID: 19022156
[TBL] [Abstract][Full Text] [Related]
8. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
Mora S; Ridker PM
Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol, cholesterol-lowering agents/statins, and urologic disease: Part V--Statins versus aspirin for primary prevention, and the winner is...?
Moyad MA; Merrick GS
Urol Nurs; 2007 Apr; 27(2):166-8. PubMed ID: 17494461
[TBL] [Abstract][Full Text] [Related]
10. [Does statin therapy reduce the risk of stroke? A meta-analysis].
Sirol M; Bouzamondo A; Sanchez P; Lechat P
Ann Med Interne (Paris); 2001 Apr; 152(3):188-93. PubMed ID: 11431579
[TBL] [Abstract][Full Text] [Related]
11. The numbers are in: statins for the primary prevention of cardiovascular disease in women.
Duvernoy CS; Blumenthal R
Circulation; 2010 Mar; 121(9):1063-5. PubMed ID: 20176993
[No Abstract] [Full Text] [Related]
12. Primary prevention for cardiovascular diseases: can statins replace aspirin?
Abdul Hadi M; Ming LC; Awaisu A
Med Princ Pract; 2011; 20(6):584. PubMed ID: 21986022
[No Abstract] [Full Text] [Related]
13. Statins for the primary prevention of cardiovascular events in elderly patients: a picture from clinical practice without strong evidence from clinical trials.
Trifirò G; Alacqua M; Corrao S; Tari M; Arcoraci V
J Am Geriatr Soc; 2008 Jan; 56(1):175-7. PubMed ID: 18184214
[No Abstract] [Full Text] [Related]
14. The JUPITER Trial: responding to the critics.
Ridker PM; Glynn RJ
Am J Cardiol; 2010 Nov; 106(9):1351-6. PubMed ID: 21029837
[No Abstract] [Full Text] [Related]
15. By Jove! What is a clinician to make of JUPITER?
Kaul S; Morrissey RP; Diamond GA
Arch Intern Med; 2010 Jun; 170(12):1073-7. PubMed ID: 20585074
[No Abstract] [Full Text] [Related]
16. The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.
Kones R
Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):309-15. PubMed ID: 19460829
[TBL] [Abstract][Full Text] [Related]
17. Update on statins and other lipid-lowering drugs.
Miller CA
Geriatr Nurs; 2001; 22(5):276-7. PubMed ID: 11606910
[No Abstract] [Full Text] [Related]
18. Primary prevention using statins: to be or not to be?
Breimer LH; Mikhailidis DP
Curr Med Res Opin; 2010 Nov; 26(11):2701-6. PubMed ID: 20954857
[No Abstract] [Full Text] [Related]
19. Is it appropriate to make statins available over the counter? Over-the-counter statins are worth considering in primary prevention of cardiovascular disease.
Gotto AM
Circulation; 2006 Sep; 114(12):1310-4; discussion 1314. PubMed ID: 16982952
[No Abstract] [Full Text] [Related]
20. Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials.
Mills EJ; Wu P; Chong G; Ghement I; Singh S; Akl EA; Eyawo O; Guyatt G; Berwanger O; Briel M
QJM; 2011 Feb; 104(2):109-24. PubMed ID: 20934984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
